Showing results (311-320 of 357) with videos related to

Sort By:
Pageof 36
Pharmacotherapy|October 21, 2025
High-Throughput Screening for Prescribing Cascades Among Real-World Angiotensin-II Receptor Blockers (ARBs) InitiatorsAsinamai M Ndai, Kayla Smith, Shailina Keshwani, et al.
Clinical Pharmacology and Therapeutics|March 13, 2025
Establishment of a Biomarker-Directed Clinical Endpoint Model for Early-Stage Parkinson's Disease PatientsChurni Gupta, Chaejin Kim, Serge Guzy, et al.
Scientific Reports|January 8, 2025
Worse survival of hepatocellular cancer patients with membranous insulin receptor overexpressionSteffen Markus Heckl, Carolin Schneider, Lukas Kercher, et al.
Journal of Medicinal Chemistry|January 26, 2022
Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 InhibitorsMirko Scortichini, Riham Mohammed Idris, Susanne Moschütz, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Building Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid PhaseSarah Kim, Walter M Yamada, Brandon Duncanson, et al.
Journal of Clinical Pharmacology|February 28, 2018
Regulatory Perspectives in Pharmacometric Models of OsteoporosisKumpal Madrasi, Fang Li, Myong-Jin Kim, et al.
Chemmedchem|November 18, 2020
Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 ReceptorsStefan Wagner, Fernando de Moura Gatti, Daniel G Silva, et al.
Journal of Clinical Pharmacology|May 16, 2019
Evaluating the Clinical Impact of Formulation Variability: A Metoprolol Extended-Release Case StudySarah Kim, Vishnu D Sharma, Karthik Lingineni, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 3, 2024
Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development toolJuan Francisco Morales, Marian Klose, Yannick Hoffert, et al.
Pageof 36